<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e895b-c663-7ff3-bdc3-6981a3d0e50b,g:77b7d393-e2af-45c2-b75d-8f5203727c9b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="abos-20260630.xsd#CondensedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e895b-c730-774a-b703-62fd86601021" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e895b-c730-79c7-8e12-daeeb80b80b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e895b-c730-774a-b703-62fd86601021" xlink:to="loc_us-gaap_AssetsCurrent_019e895b-c730-79c7-8e12-daeeb80b80b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019e895b-c730-7f4e-920f-2d242f5e20f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e895b-c730-774a-b703-62fd86601021" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019e895b-c730-7f4e-920f-2d242f5e20f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c730-714c-8b2b-f2c3d5be78eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e895b-c730-774a-b703-62fd86601021" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c730-714c-8b2b-f2c3d5be78eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e895b-c730-787a-a6cb-80c825abb116" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e895b-c730-7bf1-922a-b4e0a7fad42d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e895b-c730-787a-a6cb-80c825abb116" xlink:to="loc_us-gaap_PreferredStockValue_019e895b-c730-7bf1-922a-b4e0a7fad42d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e895b-c730-77fa-829a-acf6f0793aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e895b-c730-787a-a6cb-80c825abb116" xlink:to="loc_us-gaap_CommonStockValue_019e895b-c730-77fa-829a-acf6f0793aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019e895b-c730-7abe-9f3f-d0773a0df4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e895b-c730-787a-a6cb-80c825abb116" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019e895b-c730-7abe-9f3f-d0773a0df4fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e895b-c730-7d9d-81f5-107a504030c3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e895b-c730-787a-a6cb-80c825abb116" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e895b-c730-7d9d-81f5-107a504030c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e895b-c730-74cb-9469-d3ab87354a00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e895b-c730-787a-a6cb-80c825abb116" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e895b-c730-74cb-9469-d3ab87354a00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e895b-c730-7002-b70e-aad88c18745e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e895b-c730-7678-86bd-0dc4dfbf7d61" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e895b-c730-7002-b70e-aad88c18745e" xlink:to="loc_us-gaap_Liabilities_019e895b-c730-7678-86bd-0dc4dfbf7d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e895b-c730-75e1-adcf-d5b7ee462686" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e895b-c730-7002-b70e-aad88c18745e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e895b-c730-75e1-adcf-d5b7ee462686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e895b-c730-7904-add8-5a9c9e9d6e90" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e895b-c730-7002-b70e-aad88c18745e" xlink:to="loc_us-gaap_StockholdersEquity_019e895b-c730-7904-add8-5a9c9e9d6e90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e895b-c730-7102-b7aa-205582b9ffd3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e895b-c730-77b8-94ff-af6613b88679" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e895b-c730-7102-b7aa-205582b9ffd3" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e895b-c730-77b8-94ff-af6613b88679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019e895b-c730-7fec-b26a-409ca5a483f5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e895b-c730-7102-b7aa-205582b9ffd3" xlink:to="loc_us-gaap_LongTermDebt_019e895b-c730-7fec-b26a-409ca5a483f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e895b-c730-7665-adf8-8386aa451b09" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_AccruedClinicalTrialExpensesCurrent_019e895b-c730-7f3b-b555-341af5f6d324" xlink:href="abos-20260630.xsd#abos_AccruedClinicalTrialExpensesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e895b-c730-7665-adf8-8386aa451b09" xlink:to="loc_abos_AccruedClinicalTrialExpensesCurrent_019e895b-c730-7f3b-b555-341af5f6d324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e895b-c730-7618-a0f0-4800128997f2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e895b-c730-7665-adf8-8386aa451b09" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e895b-c730-7618-a0f0-4800128997f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019e895b-c730-71fb-b24f-3a05f2102908" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e895b-c730-7665-adf8-8386aa451b09" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019e895b-c730-71fb-b24f-3a05f2102908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_019e895b-c730-76b8-a2cb-7eb337b77cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e895b-c730-7665-adf8-8386aa451b09" xlink:to="loc_us-gaap_ShortTermBorrowings_019e895b-c730-76b8-a2cb-7eb337b77cd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e895b-c730-7188-be98-1505dfca64fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_019e895b-c730-7a45-a559-0c826b8a81e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e895b-c730-7188-be98-1505dfca64fe" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_019e895b-c730-7a45-a559-0c826b8a81e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e895b-c730-71ee-b030-b7576e791ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e895b-c730-7188-be98-1505dfca64fe" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e895b-c730-71ee-b030-b7576e791ba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c730-7259-9236-831de2306898" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e895b-c730-7188-be98-1505dfca64fe" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c730-7259-9236-831de2306898" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="abos-20260630.xsd#CondensedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e895b-c731-72a1-a7eb-01a84d66a98a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019e895b-c731-70bf-bb1f-3b32e505ad36" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e895b-c731-72a1-a7eb-01a84d66a98a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019e895b-c731-70bf-bb1f-3b32e505ad36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e895b-c731-7f4d-8cbd-4abf679e55e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e895b-c731-72a1-a7eb-01a84d66a98a" xlink:to="loc_us-gaap_NetIncomeLoss_019e895b-c731-7f4d-8cbd-4abf679e55e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c731-7254-9d95-8de5d98b6732" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019e895b-c731-7a1c-a87a-f5a567686d57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c731-7254-9d95-8de5d98b6732" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019e895b-c731-7a1c-a87a-f5a567686d57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019e895b-c731-7f11-9eba-e858e4f3cc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c731-7254-9d95-8de5d98b6732" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019e895b-c731-7f11-9eba-e858e4f3cc3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e895b-c731-719f-8ace-5883ee39c832" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c731-7254-9d95-8de5d98b6732" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e895b-c731-719f-8ace-5883ee39c832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019e895b-c731-78b4-9925-4380310363f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c731-7254-9d95-8de5d98b6732" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019e895b-c731-78b4-9925-4380310363f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e895b-c731-75d7-98d8-16057f159839" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e895b-c731-74b8-b2df-9882e1ec40bd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e895b-c731-75d7-98d8-16057f159839" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e895b-c731-74b8-b2df-9882e1ec40bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c731-757e-bc29-5b67c9c2bef1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e895b-c731-75d7-98d8-16057f159839" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c731-757e-bc29-5b67c9c2bef1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e895b-c731-7f75-b1f8-93d24020eeec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e895b-c731-7690-825c-17f91caadf36" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e895b-c731-7f75-b1f8-93d24020eeec" xlink:to="loc_us-gaap_OperatingExpenses_019e895b-c731-7690-825c-17f91caadf36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e895b-c731-7510-9b12-8c7214a3f0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e895b-c731-7100-9ef7-30c45cf05740" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e895b-c731-7510-9b12-8c7214a3f0a1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e895b-c731-7100-9ef7-30c45cf05740" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e895b-c731-7ad8-b699-97a86dfdbe45" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e895b-c731-7510-9b12-8c7214a3f0a1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e895b-c731-7ad8-b699-97a86dfdbe45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="abos-20260630.xsd#CondensedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019e895b-c731-76a5-9671-f537e5b96268" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e895b-c731-7a11-9222-b574903cbe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019e895b-c731-76a5-9671-f537e5b96268" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e895b-c731-7a11-9222-b574903cbe1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7afb-b82a-b3859000aa18" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019e895b-c731-76a5-9671-f537e5b96268" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7afb-b82a-b3859000aa18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e895b-c731-7b33-a1b3-a2e5f7489291" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019e895b-c731-76a5-9671-f537e5b96268" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e895b-c731-7b33-a1b3-a2e5f7489291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e895b-c731-7fe3-a89a-d1d6f5c8d32b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019e895b-c731-7841-b1dc-0485d53eea7a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e895b-c731-7fe3-a89a-d1d6f5c8d32b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019e895b-c731-7841-b1dc-0485d53eea7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019e895b-c731-79f4-a836-221c09e6be22" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e895b-c731-7fe3-a89a-d1d6f5c8d32b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019e895b-c731-79f4-a836-221c09e6be22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019e895b-c731-769c-9efc-f2a338f11d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e895b-c731-7fe3-a89a-d1d6f5c8d32b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019e895b-c731-769c-9efc-f2a338f11d0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e895b-c731-78e1-9b57-a182122d1213" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_019e895b-c731-7d1f-a901-a212a8a526a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e895b-c731-78e1-9b57-a182122d1213" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_019e895b-c731-7d1f-a901-a212a8a526a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_019e895b-c731-70fb-9f22-da30f9c53409" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e895b-c731-78e1-9b57-a182122d1213" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_019e895b-c731-70fb-9f22-da30f9c53409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_019e895b-c731-7132-a35e-fcd0fdbadf52" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e895b-c731-78e1-9b57-a182122d1213" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_019e895b-c731-7132-a35e-fcd0fdbadf52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e895b-c731-74b5-b020-aeb6c4831b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_NetIncomeLoss_019e895b-c731-74b5-b020-aeb6c4831b5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019e895b-c731-7bca-ab58-0418c17cd50a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_Depreciation_019e895b-c731-7bca-ab58-0418c17cd50a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e895b-c731-7f3b-a05f-7548bb1efdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_ShareBasedCompensation_019e895b-c731-7f3b-a05f-7548bb1efdcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e895b-c731-7030-8015-865f6a4bcac0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e895b-c731-7030-8015-865f6a4bcac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019e895b-c731-72ee-9573-c19554f5654e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019e895b-c731-72ee-9573-c19554f5654e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e895b-c731-7cbc-b0ae-b9f22d00e6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e895b-c731-7cbc-b0ae-b9f22d00e6b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_019e895b-c731-7b32-9dd4-40018dfaec6a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_019e895b-c731-7b32-9dd4-40018dfaec6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_OtherNoncashExpenseInterest_019e895b-c731-79a2-bca3-58bc1a74d73f" xlink:href="abos-20260630.xsd#abos_OtherNoncashExpenseInterest"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_abos_OtherNoncashExpenseInterest_019e895b-c731-79a2-bca3-58bc1a74d73f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e895b-c731-70eb-a495-4bdea5e213fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e895b-c731-70eb-a495-4bdea5e213fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019e895b-c731-7a7a-83a6-02cd89958024" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019e895b-c731-7a7a-83a6-02cd89958024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e895b-c731-761d-ba02-1596b982d358" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e895b-c731-761d-ba02-1596b982d358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_IncreaseDecreaseInAccruedClinicalTrialExpenses_019e895b-c731-784a-b545-cc90040d47c1" xlink:href="abos-20260630.xsd#abos_IncreaseDecreaseInAccruedClinicalTrialExpenses"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_abos_IncreaseDecreaseInAccruedClinicalTrialExpenses_019e895b-c731-784a-b545-cc90040d47c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e895b-c731-794b-b23f-e46fd86d4879" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e895b-c731-7bbb-aeec-e989664064b9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e895b-c731-794b-b23f-e46fd86d4879" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e895b-c731-714f-a90b-d9e7d2fcdb84" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_019e895b-c731-7478-8223-a5b7265af2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e895b-c731-714f-a90b-d9e7d2fcdb84" xlink:to="loc_us-gaap_RestrictedCash_019e895b-c731-7478-8223-a5b7265af2b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e895b-c731-7b91-b220-9a84a5e00d95" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e895b-c731-714f-a90b-d9e7d2fcdb84" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e895b-c731-7b91-b220-9a84a5e00d95" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019e895b-c731-7eb6-abce-6849016b7c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e895b-c731-78b1-9f7d-5313d784b6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019e895b-c731-7eb6-abce-6849016b7c3e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e895b-c731-78b1-9f7d-5313d784b6a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_019e895b-c731-7ad7-8995-a4d78e9e3a50" xlink:href="abos-20260630.xsd#abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019e895b-c731-7eb6-abce-6849016b7c3e" xlink:to="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_019e895b-c731-7ad7-8995-a4d78e9e3a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_019e895b-c731-7afd-90e5-bd6d63f52000" xlink:href="abos-20260630.xsd#abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019e895b-c731-7eb6-abce-6849016b7c3e" xlink:to="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_019e895b-c731-7afd-90e5-bd6d63f52000" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e895b-c731-731b-b3bf-4d642155122d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e895b-c731-785c-bf28-6fb33f8ed1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e895b-c731-731b-b3bf-4d642155122d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e895b-c731-785c-bf28-6fb33f8ed1c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e895b-c731-79bb-806d-714a069a4675" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e895b-c731-731b-b3bf-4d642155122d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e895b-c731-79bb-806d-714a069a4675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e895b-c731-7a98-8660-b41d560403dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e895b-c731-7296-ad64-9f37ce0323c6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e895b-c731-7a98-8660-b41d560403dc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e895b-c731-7296-ad64-9f37ce0323c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e895b-c731-75cf-9c63-762c1af1a30c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e895b-c731-7a98-8660-b41d560403dc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e895b-c731-75cf-9c63-762c1af1a30c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019e895b-c731-70ab-a48e-ee90b055924e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019e895b-c731-7de1-8e92-1b5b6766ae56" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019e895b-c731-70ab-a48e-ee90b055924e" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019e895b-c731-7de1-8e92-1b5b6766ae56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019e895b-c731-77da-b056-fb303cc4f4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e895b-c731-747a-aae8-2b9ca2216339" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019e895b-c731-77da-b056-fb303cc4f4c6" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e895b-c731-747a-aae8-2b9ca2216339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_019e895b-c731-70b2-962b-f7e324239ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019e895b-c731-77da-b056-fb303cc4f4c6" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_019e895b-c731-70b2-962b-f7e324239ebf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_019e895b-c7fd-7aa4-be6c-09c4c49d1a99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019e895b-c7fd-7f70-bb1b-6e753c17fc94" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous_019e895b-c7fd-7aa4-be6c-09c4c49d1a99" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019e895b-c7fd-7f70-bb1b-6e753c17fc94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019e895b-c7fd-78d4-ac59-d747488210f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous_019e895b-c7fd-7aa4-be6c-09c4c49d1a99" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019e895b-c7fd-78d4-ac59-d747488210f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-712b-8f29-49304e9c5d25" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019e895b-c731-71a3-bb3d-b100ebf474be" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentServiceAgreementsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-712b-8f29-49304e9c5d25" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019e895b-c731-71a3-bb3d-b100ebf474be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_019e895b-c731-76e2-af0b-1f96ada06600" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-712b-8f29-49304e9c5d25" xlink:to="loc_us-gaap_OtherReceivables_019e895b-c731-76e2-af0b-1f96ada06600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019e895b-c731-7ed4-abf8-8c0b83fb98c4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-712b-8f29-49304e9c5d25" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019e895b-c731-7ed4-abf8-8c0b83fb98c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019e895b-c731-74a8-aabd-93ee3264c7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-712b-8f29-49304e9c5d25" xlink:to="loc_us-gaap_PrepaidInsurance_019e895b-c731-74a8-aabd-93ee3264c7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DuesAndSubscriptions_019e895b-c731-77ea-aa97-09e51db7dd43" xlink:href="abos-20260630.xsd#abos_DuesAndSubscriptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-712b-8f29-49304e9c5d25" xlink:to="loc_abos_DuesAndSubscriptions_019e895b-c731-77ea-aa97-09e51db7dd43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreements_019e895b-c731-7b02-98ab-947297450723" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentServiceAgreements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreements_019e895b-c731-7b02-98ab-947297450723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_019e895b-c731-719f-b106-de808883b278" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_019e895b-c731-719f-b106-de808883b278" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_019e895b-c731-72ff-bbbd-e7ec06a39f56" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:to="loc_us-gaap_OtherReceivables_019e895b-c731-72ff-bbbd-e7ec06a39f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e895b-c731-7d6f-b805-c0ecc4a359af" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e895b-c731-7d6f-b805-c0ecc4a359af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019e895b-c731-7115-b4b6-26358f72bc01" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:to="loc_us-gaap_PrepaidInsurance_019e895b-c731-7115-b4b6-26358f72bc01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DuesAndSubscriptions_019e895b-c731-7b0f-81e1-f8ef4cbe9f5a" xlink:href="abos-20260630.xsd#abos_DuesAndSubscriptions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:to="loc_abos_DuesAndSubscriptions_019e895b-c731-7b0f-81e1-f8ef4cbe9f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e895b-c731-77f7-a236-fd0cf48bbec2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-74dc-a065-a0815188d141" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e895b-c731-77f7-a236-fd0cf48bbec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreements_019e895b-c731-7fae-b531-8380827be66f" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentServiceAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019e895b-c731-72ab-bde1-b379d52810d0" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentServiceAgreementsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_abos_ResearchAndDevelopmentServiceAgreements_019e895b-c731-7fae-b531-8380827be66f" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019e895b-c731-72ab-bde1-b379d52810d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019e895b-c7fd-7c5d-a104-866218ca11b6" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentServiceAgreementsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_abos_ResearchAndDevelopmentServiceAgreements_019e895b-c731-7fae-b531-8380827be66f" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019e895b-c7fd-7c5d-a104-866218ca11b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c7fd-7fe3-8c35-e98fe9420e68" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e895b-c7fd-75e1-bf8a-c6b9bfcb8926" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c7fd-7fe3-8c35-e98fe9420e68" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e895b-c7fd-75e1-bf8a-c6b9bfcb8926" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e895b-c7fd-7d1f-b632-ae13caa75fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c7fd-7fe3-8c35-e98fe9420e68" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e895b-c7fd-7d1f-b632-ae13caa75fbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019e895b-c7fd-734b-a11d-9edbc7994ac6" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentServiceAgreementsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c7fd-7fe3-8c35-e98fe9420e68" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019e895b-c7fd-734b-a11d-9edbc7994ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019e895b-c7fd-76b4-a58a-6eadeab9e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c7fd-7fe3-8c35-e98fe9420e68" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019e895b-c7fd-76b4-a58a-6eadeab9e39e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1" xlink:type="simple" xlink:href="abos-20260630.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-73b2-8580-9d8afe7bebf3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c731-79ff-bf46-11a8e76c2e94" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-73b2-8580-9d8afe7bebf3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e895b-c731-79ff-bf46-11a8e76c2e94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-7e2c-9a4b-cef2e89f014f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019e895b-c731-73b2-8580-9d8afe7bebf3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e895b-c731-7e2c-9a4b-cef2e89f014f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019e895b-c7fd-7103-a856-0e222b3f2c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentLiability_019e895b-c7fd-7404-84ea-bdb8dc078958" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019e895b-c7fd-7103-a856-0e222b3f2c4e" xlink:to="loc_abos_ResearchAndDevelopmentLiability_019e895b-c7fd-7404-84ea-bdb8dc078958" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_019e895b-c7fd-7296-929f-66ed993bf34f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019e895b-c7fd-7103-a856-0e222b3f2c4e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_019e895b-c7fd-7296-929f-66ed993bf34f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019e895b-c7fd-7c64-94d7-7ae067a345cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019e895b-c7fd-7103-a856-0e222b3f2c4e" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019e895b-c7fd-7c64-94d7-7ae067a345cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019e895b-c7fd-741b-8945-0b8c5d1e7400" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019e895b-c7fd-7103-a856-0e222b3f2c4e" xlink:to="loc_us-gaap_OperatingLeaseLiability_019e895b-c7fd-741b-8945-0b8c5d1e7400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilities_019e895b-c7fd-7705-a980-5477b2796c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherSundryLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019e895b-c7fd-7103-a856-0e222b3f2c4e" xlink:to="loc_us-gaap_OtherSundryLiabilities_019e895b-c7fd-7705-a980-5477b2796c9a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#DEBTScheduleofOutstandingDebtDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019e895b-c7fd-7aa5-8bb3-ade0ebee383e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_019e895b-c7fd-71b1-b4ca-b388277810ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019e895b-c7fd-7aa5-8bb3-ade0ebee383e" xlink:to="loc_us-gaap_ShortTermBorrowings_019e895b-c7fd-71b1-b4ca-b388277810ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019e895b-c7fd-771d-8d6a-bcdcb911db82" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019e895b-c7fd-7aa5-8bb3-ade0ebee383e" xlink:to="loc_us-gaap_LongTermDebt_019e895b-c7fd-771d-8d6a-bcdcb911db82" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails_1" xlink:type="simple" xlink:href="abos-20260630.xsd#DEBTScheduleofOutstandingDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019e895b-c7fd-760b-9f65-6727949938c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019e895b-c7fd-7f9e-82a7-5217c2a0c7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019e895b-c7fd-760b-9f65-6727949938c7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_019e895b-c7fd-7f9e-82a7-5217c2a0c7d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019e895b-c7fd-7fc6-9bdb-01495b008664" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019e895b-c7fd-760b-9f65-6727949938c7" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019e895b-c7fd-7fc6-9bdb-01495b008664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019e895b-c7fd-7497-a0a2-01c2b6810ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019e895b-c7fd-760b-9f65-6727949938c7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019e895b-c7fd-7497-a0a2-01c2b6810ed6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofInterestExpenseDebtDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#DEBTScheduleofInterestExpenseDebtDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofInterestExpenseDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_019e895b-c7fd-7337-b36f-845befccc46a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_019e895b-c7fd-7288-a6d7-58d3a8a1f0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_019e895b-c7fd-7337-b36f-845befccc46a" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_019e895b-c7fd-7288-a6d7-58d3a8a1f0a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019e895b-c7fd-785b-8689-fdbdc9125e38" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_019e895b-c7fd-7337-b36f-845befccc46a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019e895b-c7fd-785b-8689-fdbdc9125e38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofAggregatePrincipalPaymentsDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#DEBTScheduleofAggregatePrincipalPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofAggregatePrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019e895b-c7fd-7b23-b369-5e31d0ca2211" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019e895b-c7fd-72a8-9627-e388aa9ee59d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_019e895b-c7fd-7b23-b369-5e31d0ca2211" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019e895b-c7fd-72a8-9627-e388aa9ee59d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019e895b-c7fd-705c-b983-8cadd1bce662" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_019e895b-c7fd-7b23-b369-5e31d0ca2211" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019e895b-c7fd-705c-b983-8cadd1bce662" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SEGMENTREPORTINGScheduleofSegmentReportingInformationDetails" xlink:type="simple" xlink:href="abos-20260630.xsd#SEGMENTREPORTINGScheduleofSegmentReportingInformationDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SEGMENTREPORTINGScheduleofSegmentReportingInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e895b-c7fe-77c1-84d9-1e73f9aeca06" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019e895b-c7fe-7fd9-b1cf-a341768bb699" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e895b-c7fe-77c1-84d9-1e73f9aeca06" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019e895b-c7fe-7fd9-b1cf-a341768bb699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c7fe-729c-9581-3370fbefa015" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e895b-c7fe-77c1-84d9-1e73f9aeca06" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019e895b-c7fe-729c-9581-3370fbefa015" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentExternalCosts_019e895b-c7fe-757d-8c74-cee26f5adf56" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentExternalCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e895b-c7fe-77c1-84d9-1e73f9aeca06" xlink:to="loc_abos_ResearchAndDevelopmentExternalCosts_019e895b-c7fe-757d-8c74-cee26f5adf56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e895b-c7fe-748e-bff3-0cdcd3c118ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e895b-c7fe-77c1-84d9-1e73f9aeca06" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e895b-c7fe-748e-bff3-0cdcd3c118ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentInternallyManagedCosts_019e895b-c7fe-785f-b265-bacf1f23ff03" xlink:href="abos-20260630.xsd#abos_ResearchAndDevelopmentInternallyManagedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e895b-c7fe-77c1-84d9-1e73f9aeca06" xlink:to="loc_abos_ResearchAndDevelopmentInternallyManagedCosts_019e895b-c7fe-785f-b265-bacf1f23ff03" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
